Sage Therapeutics Inc (STU:SG7) Stock News, Headlines & Updates
Sage Therapeutics Inc Stock News from GuruFocus
- 1
Jun 11, 2024
Sage Therapeutics Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington's Disease
Business Wire • 6:00am
Jun 05, 2024
Sage Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Business Wire • 6:00am
May 31, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
PRNewswire • 7:00pm
May 28, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors Sage Therapeutics, Inc. -- SAGE
Marketwired • 4:00pm
May 23, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
PRNewswire • 12:00pm
May 21, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
Marketwired • 11:00am
May 17, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE
PRNewswire • 9:00pm
May 12, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
Marketwired • 10:00am
May 07, 2024
Sage Therapeutics to Participate in Upcoming May Investor Conferences
Business Wire • 6:00am
May 06, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
PRNewswire • 6:00pm
May 02, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
Marketwired • 3:00pm
Apr 28, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
PRNewswire • 9:00am
Apr 26, 2024
Q1 2024 SAGE Therapeutics Inc Earnings Call Transcript
GuruFocus Research • 11:14pm
Apr 25, 2024
Sage Therapeutics Inc (SAGE) Q1 2024 Earnings: Mixed Results Amidst Pipeline Progress
GuruFocus Research • 6:04am
Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
Business Wire • 6:00am
Apr 24, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
Marketwired • 10:00am
Apr 17, 2024
Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson's Disease
Business Wire • 6:00am
Apr 11, 2024
Sage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024
Business Wire • 6:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news